Our Portfolio
Direct Investments
We take an active role in our portfolio companies, contributing expertise in drug discovery, development and operations, to help them deliver maximum patient value.
switchthera.comSwitch Therapeutics is a San Francisco based biotech developing conditionally activated siRNA technology for central nervous system diseases.
codebiotx.comCode Bio is developing transformational, non-viral, genetic medicines to treat and potentially cure serious and life-threatening diseases
splice.bioSpliceBio is a biotechnology company exploiting protein splicing to develop the next generation of gene therapies
neuronatherapeutics.comNeurona is a cell therapy company focused on the development of breakthrough treatments for neurological disorders.
waldenbiosciences.comWalden Biosciences, Inc., a biotechnology company focused on transforming the treatment of kidney disease.
rinri-therapeutics.comRinri Therapeutics is a biotechnology company developing advanced stem cell-based therapeutics to treat hearing loss.
exevir.comExeVir Bio is an VHH antiviral platform company focused on rapid control with a lead compound for COVID-19.
www.vianautis.comViaNautis is developing a nanovesicle platform designed to deliver genetic therapeutic payloads to the specific site of action with unparalleled precision.
https://irismedicine.comIris Medicine is developing a unique RNA therapeutics platform that enables universal allele selectivity in treating genetic diseases.
https://seamlesstx.comSeamless is developing a unique approach to gene editing using programmable recombinases to address genetic disease.
https://cenostx.comCenos is pioneering a blood-brain barrier shuttle platform to address neurological diseases with high unmet needs.
Selected Invested Funds
arixbioscience.comarixbioscience.com Arix Bioscience supports medical innovation at all stages of development and has access to breakthrough academic science.
pappas-capital.comaPappas is dedicated to furthering life science discoveries and delivering groundbreaking solutions to market.
qimingvc.comQiming drives innovation and growth of business enterprises and promotes overall industry advancement and social development.
Exited
syndesitherapeutics.com
Syndesi Therapeutics is developing novel modulators of the synaptic vesicle protein SV2A to address disorders of cognition. Acquired by AstraZeneca.
Ally Therapeutics
Ally Therapeutics is a gene therapy company spun out of Harvard.
stridebio.comStrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies.
locanabio.comLocana, Inc. is an RNA-targeting gene therapy company with a platform technology to address a wide spectrum of human genetic diseases.
esobiotec.comEsoBiotec is a biotechnology company developing an in vivo engineering platform to produce cancer fighting cells inside the patient’s body. Acquired by AstraZeneca.
